We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$88B
AUM Growth
+$3.05B
(+3.6%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-3.73%
Top 10 Holdings %
Top 10 Hldgs %
12.89%
Holding
2,253
New
146
Increased
815
Reduced
1,092
Closed
142
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$267M |
| 2 |
Home Depot
HD
|
+$252M |
| 3 |
Northrop Grumman
NOC
|
+$221M |
| 4 |
Gilead Sciences
GILD
|
+$175M |
| 5 |
Dollar General
DG
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HP
HPQ
|
+$287M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$278M |
| 3 |
Biogen
BIIB
|
+$244M |
| 4 |
iShares Russell 3000 ETF
IWV
|
+$198M |
| 5 |
Exelon
EXC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.05% |
| 2 | Financials | 14.3% |
| 3 | Healthcare | 13.64% |
| 4 | Consumer Discretionary | 13.24% |
| 5 | Industrials | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MFA
2001
MFA Financial
MFA
$933M
| $211K | ﹤0.01% |
6,889
| – | – |
|
|
CDMO
2002
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $209K | ﹤0.01% |
27,286
| – | – |
|
|
GNMK
2003
DELISTED
GenMark Diagnostics, Inc
GNMK
| $209K | ﹤0.01% |
43,420
-82,446
| -66% | -$455K |
|
2004
Ovintiv
OVV
$16.4B
| $208K | ﹤0.01% |
8,865
-1,010
| -10% | -$21.6K |
|
|
IOTS
2005
DELISTED
Adesto Technologies Corp
IOTS
| $208K | ﹤0.01% |
24,438
+13,154
| +117% | +$103K |
|
2006
Horizon Bancorp
HBNC
$1.04B
| $207K | ﹤0.01% |
10,892
+532
| +5% | +$9.76K |
|
|
OTRK
2007
DELISTED
Ontrak
OTRK
| $206K | ﹤0.01% |
140
| – | – |
|
2008
Webster Financial
WBS
$12.8B
| $203K | ﹤0.01% |
+3,795
| New | +$183K |
|
|
RFP
2009
DELISTED
Resolute Forest Products Inc.
RFP
| $202K | ﹤0.01% |
47,999
-194,431
| -80% | -$807K |
|
|
CHMA
2010
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $202K | ﹤0.01% |
40,695
| – | – |
|
2011
Tucows
TCX
$175M
| $201K | ﹤0.01% |
+3,256
| New | +$186K |
|
|
RDFN
2012
DELISTED
Redfin
RDFN
| $200K | ﹤0.01% |
+9,468
| New | +$181K |
|
2013
WillScot Mobile Mini Holdings
WSC
$4.41B
| $200K | ﹤0.01% |
+10,794
| New | +$181K |
|
|
GLUU
2014
DELISTED
Glu Mobile Inc.
GLUU
| $197K | ﹤0.01% |
32,490
-617,791
| -95% | -$3.53M |
|
|
CALA
2015
DELISTED
Calithera Biosciences, Inc
CALA
| $194K | ﹤0.01% |
+1,698
| New | +$128K |
|
2016
Kinross Gold
KGC
$32.8B
| $193K | ﹤0.01% |
40,666
-1,523
| -4% | -$6.87K |
|
2017
AGNC Investment
AGNC
$12.9B
| $190K | ﹤0.01% |
10,721
| – | – |
|
|
EMWP
2018
DELISTED
Eros Media World PLC
EMWP
| $189K | ﹤0.01% |
2,786
-12,981
| -82% | -$606K |
|
|
UMH
2019
UMH Properties
UMH
$1.36B
| $186K | ﹤0.01% |
11,835
+470
| +4% | +$7.09K |
|
2020
Clean Energy Fuels
CLNE
$346M
| $185K | ﹤0.01% |
79,140
-47,320
| -37% | -$100K |
|
|
CHS
2021
DELISTED
Chicos FAS, Inc.
CHS
| $183K | ﹤0.01% |
48,027
-15,904
| -25% | -$61.1K |
|
|
ADMS
2022
DELISTED
Adamas Pharmaceuticals
ADMS
| $181K | ﹤0.01% |
+47,708
| New | +$228K |
|
2023
GameStop
GME
$8.6B
| $180K | ﹤0.01% |
118,668
-1,081,940
| -90% | -$1.59M |
|
2024
MarineMax
HZO
$788M
| $176K | ﹤0.01% |
10,550
-11,021
| -51% | -$180K |
|
2025
FNB Corp
FNB
$6.75B
| $175K | ﹤0.01% |
+13,793
| New | +$169K |
|
Similar funds
VGA
AQR Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, AQR Capital Management held 2,253 positions worth $88B, up 3.6% from $84.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management withdrew a net $3.28B in Q4 2019, closing 142 positions and reducing 1,092 holdings. Its most notable exit was iShares Russell 3000 ETF, an estimated $198M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, AQR Capital Management opened a new position in DaVita worth $31.1M.
- AQR Capital Management's largest Q4 2019 buy was DaVita: 417,883 shares worth $31.1M.
- AQR Capital Management added most to Humana in Q4 2019, an estimated $267M increase.
- AQR Capital Management's biggest Q4 2019 reduction was HP, cutting an estimated $287M.
- AQR Capital Management fully exited iShares Russell 3000 ETF in Q4 2019, selling an estimated $198M.
- AQR Capital Management's ten largest holdings make up 13% of its $88B portfolio in Q4 2019.
- AQR Capital Management opened 146 new positions and closed 142 in Q4 2019.
- AQR Capital Management's portfolio value rose 3.6% quarter-over-quarter to $88B.
Based on AQR Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.